CLINICAL_TRIALS
trial_result
· 2025-10-29
Clinical Trial Update: Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial update evaluating the combination of nivolumab and axitinib in patients with advanced renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fox Chase Cancer Center | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING